Search

Cell biologist Philipp Niethammer discusses what the zebrafish can teach us about how the body heals.

… Wednesday, July 15, 2015 VIDEO | 00:04 Watch: The Body’s Immune Response In Action Video Details Summary An overactive immune system can lead to diseases, including cancer. In this Q&A, cell biologist Philipp Niethammer talks about his work studying inflammation and wound repair in zebrafish. Highlights

At MSK we have developed a highly accurate, low-cost assay, for identifying early-stage oral and anal cancers associated with human papillomavirus (HPV) using liquid biopsy.

… Tuesday, December 10, 2019 Together with my colleagues at Memorial Sloan Kettering Cancer Center, we developed a highly accurate assay for identifying early-stage oral and anal cancers associated with human papillomavirus (HPV) using liquid biopsy. This low-cost technique could be advantageous in early

Learn about the Chief Strategy Officer at MSK, Anaeze Offodile, MD, MPH.

… Tuesday, September 3, 2024 “We are in a moment of historic change in cancer care,” says Anaeze Offodile, MD, MPH . Dr. Offodile joined Memorial Sloan Kettering Cancer Center (MSK) in 2023 as Chief Strategy Officer, after serving as the Executive Director for Clinical Transformation at MD Anderson. Among

In patients with progressive, refractory, or symptomatic desmoid tumors, sorafenib (Nexavar®) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective in slowing disease progression.

… Wednesday, December 19, 2018 Bottom Line: In patients with progressive, refractory, or symptomatic desmoid tumors , sorafenib (Nexavar ® ) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective

Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation.

… Thursday, January 14, 2021 Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation, according to our research published online first in Ophthalmology Retina . Worldwide, removing the affected eye has been the standard

可通过眼动脉化学外科 (OAC) 方式对视网膜母细胞瘤伴脉络膜侵犯的患者进行成功治疗，避免眼球摘除。

… Thursday, January 14, 2021 我们首次在线发表在 《眼科视网膜》(Ophthalmology Retina) 上的研究表明，对视网膜母细胞瘤伴脉络膜侵犯的患者，可以通过眼动脉化学外科 (OAC) 方式进行成功治疗，避免眼球摘除。 在世界范围内，摘除受累一侧的眼球一直是管理脉络膜浸润的标准方式。 近期，有很多临床医生开始质疑视网膜母细胞瘤伴脉络膜浸润是否真正有较高的转移率，患者是否有必要进行眼球摘除和多药辅助全身化疗的高强度治疗。  (1) 我们对包含 4 例双侧视网膜母细胞瘤儿童患者的小型病例系列进行了一项回顾性综述，这些患者均伴随有大量直径大于 3 毫米的脉络膜浸润病灶

A new imaging approach involving lasers and sound waves produces high-resolution pictures of tumor blood vessels.

… Wednesday, March 18, 2020 Summary Cancer drugs targeting the blood vessels that nourish tumors have shown mixed results. A new laser-based, high-resolution imaging technique could be a noninvasive tool for showing how these blood vessels change in response to therapy. Cancer needs a steady supply of

MSK is celebrating National Nurses Week, which runs from May 6 to 12 every year – the end date coinciding with Florence Nightingale's birthday.

… Friday, May 8, 2020 MSK Celebrates National Nurses Week Kevin Browne MSK is celebrating National Nurses Week, which runs from May 6 to 12 every year – the end date coinciding with Florence Nightingale’s birthday. This year marks the 200 th anniversary of her birth, prompting the World Health Organization

Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.

… Wednesday, July 26, 2023 Liquid biopsies have the potential to revolutionize cancer diagnosis and treatment decisions. Unlike biopsies that require removing tumor tissue, these tests use a simple blood draw to assess the molecular characteristics of cancer. Liquid biopsies can be done repeatedly and

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.

… Tuesday, February 27, 2018 Summary Being able to find the genetic mutations that drive individual cells within a tumor may lead to better targeted therapies. Precision oncology is based on the idea that the molecular changes driving cancer can be targeted with drugs to stop a tumor from growing. But